Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Xiuming Zhang, Wei Qiao, Zheng Kang, Chunhan Pan, Yan Chen, Kang Li, Wenrong Shen & Lei Zhang. (2022) CT Features of Stage IA Invasive Mucinous Adenocarcinoma of the Lung and Establishment of a Prediction Model. International Journal of General Medicine 15, pages 5455-5463.
Read now
Read now
Rumeng Gu, Ziling Shi, Ting Duan & Meijun Song. (2021) Feasibility and Safety of Neoadjuvant Alectinib in Pulmonary Invasive Mucinous Adenocarcinoma with ALK Rearrangement: Case Report and Literature Review. OncoTargets and Therapy 14, pages 5107-5113.
Read now
Read now
Articles from other publishers (19)
Xiaolin Sun, Baozhen Zeng, Xiaoyue Tan, Zhijian Chen, Xiaoqiang Pan & Lei Jiang. (2022) Invasive mucinous adenocarcinoma of the lung: clinicopathological features, 18F-FDG PET/CT findings, and survival outcomes. Annals of Nuclear Medicine 37:3, pages 198-207.
Crossref
Crossref
Muneo Kawasumi, Yusuke Araki, Mineyo Mito, Kazuhide Fukuhara, Junichi Zaitsu, Kazuya Kuraoka & Tadashi Senoo. (2023) A Case of Invasive Mucinous Adenocarcinoma with Acute Respiratory Distress Syndrome Diagnosed by Autopsy Findings. Internal Medicine.
Crossref
Crossref
Hyun Jung Yoon, Jun Kang, Ho Yun Lee, Min A. Lee, Na Young Hwang, Hong Kwan Kim & Jhingook Kim. (2022) Recurrence dynamics after curative surgery in patients with invasive mucinous adenocarcinoma of the lung. Insights into Imaging 13:1.
Crossref
Crossref
Dae Hyeon Kim, So Young Bae, Kwon Joong Na, Samina Park, In Kyu Park, Chang Hyun Kang & Young Tae Kim. (2022) Radiological and clinical features of screening-detected pulmonary invasive mucinous adenocarcinoma. Interactive CardioVascular and Thoracic Surgery 34:2, pages 229-235.
Crossref
Crossref
Ji-wen Huo, Xing-tao Huang, Xian Li, Jun-wei Gong, Tian-you Luo & Qi Li. (2021) Pneumonic-type lung adenocarcinoma with different ranges exhibiting different clinical, imaging, and pathological characteristics. Insights into Imaging 12:1.
Crossref
Crossref
Yadong Wang, Jichang Liu, Cuicui Huang, Yukai Zeng, Yong Liu & Jiajun Du. (2021) Development and validation of a nomogram for predicting survival of pulmonary invasive mucinous adenocarcinoma based on surveillance, epidemiology, and end results (SEER) database. BMC Cancer 21:1.
Crossref
Crossref
Soo-Ryum Yang, Jason C. Chang, Charles Leduc, Kay See Tan, Snjezana Dogan, Ryma Benayed, Laetitia Borsu, Michael Offin, Alexander Drilon, William D. Travis, Maria E. Arcila, Marc Ladanyi & Natasha Rekhtman. (2021) Invasive Mucinous Adenocarcinomas With Spatially Separate Lung Lesions: Analysis of Clonal Relationship by Comparative Molecular Profiling. Journal of Thoracic Oncology 16:7, pages 1188-1199.
Crossref
Crossref
Xiaoling Xu, Na Li, Ding Wang, Wei Chen & Yun Fan. (2021) Clinical Relevance of PD-L1 Expression and CD8+ T Cells’ Infiltration in Patients With Lung Invasive Mucinous Adenocarcinoma. Frontiers in Oncology 11.
Crossref
Crossref
Tingting Wang, Yang YangXinyue LiuJiajun DengJunqi WuLikun HouChunyan WuYunlang SheXiwen SunDong XieChang Chen. (2021) Primary Invasive Mucinous Adenocarcinoma of the Lung: Prognostic Value of CT Imaging Features Combined with Clinical Factors. Korean Journal of Radiology 22:4, pages 652.
Crossref
Crossref
Kyongmin Sarah Beck, Yeoun Eun Sung, Kyo Young Lee & Dae Hee Han. (2020)
Invasive mucinous adenocarcinoma of the lung: Serial
CT
findings, clinical features, and treatment and survival outcomes
. Thoracic Cancer 11:12, pages 3463-3472.
Crossref
Crossref
Ayako Aoki, Yu Hara, Koji Okudela, Yoshihiro Ishikawa, Kosei Doshita, Hisashi Hashimoto, Kentaro Nakashima, Nobuyuki Horita, Nobuaki Kobayashi & Takeshi Kaneko. (2020) Unusual lung involvements of invasive mucinous adenocarcinoma with chylothorax. Thoracic Cancer 11:11, pages 3407-3408.
Crossref
Crossref
Kazumori Arai, Tomohiro Iwasaki, Chinatsu Tsuchiya & Akihiro Sonoda. (2020) Annexin A2 Expression in the Aerogenous Spread of Pulmonary Invasive Mucinous Adenocarcinoma with Gastric Lineage. Case Reports in Oncological Medicine 2020, pages 1-9.
Crossref
Crossref
Kai Nie, Wei Nie, Yu-Xuan Zhang & Hong Yu. (2019) Comparing clinicopathological features and prognosis of primary pulmonary invasive mucinous adenocarcinoma based on computed tomography findings. Cancer Imaging 19:1.
Crossref
Crossref
Tomonari Oki, Keiju Aokage, Takuya Ueda, Masato Sugano, Kenta Tane, Tomohiro Miyoshi, Motohiro Kojima, Satoshi Fujii, Takeshi Kuwata, Atsushi Ochiai, Kazuhito Funai, Masahiro Tsuboi & Genichiro Ishii. (2019) Proportion of goblet cell is associated with malignant potential in invasive mucinous adenocarcinoma of the lung. Pathology International 69:9, pages 526-535.
Crossref
Crossref
Jia Wei, Dezhu Tang, Ying Nie, Jie Chen & Li Peng. (2019) Clinical characteristics and prognosis of nonsurgically treated patients with pneumonic-type adenocarcinoma. Medicine 98:18, pages e15420.
Crossref
Crossref
Jae-Kwang Lim, Kyung Min Shin, Hui Joong Lee, Hoseok Lee, Myong Hun Hahm, Jaehee Lee, Chang Ho Kim, Seung Ick Cha, Ji Yun Jeong & Tae-In Park. (2019) Can Quantitative Volumetric Analysis Predict Tumor Recurrence in the Patients with Mucinous Adenocarcinoma of the Lung After Surgical Resection?. Academic Radiology 26:5, pages e21-e31.
Crossref
Crossref
Shinsuke Ogusu, Koichiro Takahashi, Haruki Hirakawa, Masahide Tanaka, Kazutoshi Komiya, Tomomi Nakamura, Ryoko Egashira, Keita Kai, Yuji Takeda, Shinya Kimura & Naoko Sueoka-Aragane. (2018) Primary Pulmonary Colloid Adenocarcinoma: How Can We Obtain a Precise Diagnosis?. Internal Medicine 57:24, pages 3637-3641.
Crossref
Crossref
Saba Beigh, Hina Rashid, Shikha Sharma, Suhel Parvez & Sheikh Raisuddin. (2017) Bleomycin-induced pulmonary toxicopathological changes in rats and its prevention by walnut extract. Biomedicine & Pharmacotherapy 94, pages 418-429.
Crossref
Crossref
Ayumu Otsuki, Kei Nakashima, Masafumi Misawa & Masahiro Aoshima. (2017) A Good Response to Nivolumab in a Patient with Heavily Pre-treated <i>KRAS</i> Mutant Invasive Mucinous Adenocarcinoma. Haigan 57:7, pages 843-848.
Crossref
Crossref